Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 38 entries
Sorted by: Best Match Show Resources per page
Racial/Ethnic Differences in 30-Day Mortality for Heart Failure and Pneumonia in the Veterans Health Administration Using Claims-based, Clinical, and Social Risk-adjustment Variables.

Medical care

Silva GC, Jiang L, Gutman R, Wu WC, Mor V, Fine MJ, Kressin NR, Trivedi AN.
PMID: 34779794
Med Care. 2021 Dec 01;59(12):1082-1089. doi: 10.1097/MLR.0000000000001650.

BACKGROUND: Prior studies have identified lower mortality in Black Veterans compared with White Veterans after hospitalization for common medical conditions, but these studies adjusted for comorbid conditions identified in administrative claims.OBJECTIVES: The objectives of this study were to compare...

Cite
Silva GC, Jiang L, Gutman R, et al. Racial/Ethnic Differences in 30-Day Mortality for Heart Failure and Pneumonia in the Veterans Health Administration Using Claims-based, Clinical, and Social Risk-adjustment Variables. Med Care. 2021;59(12):1082-1089doi: 10.1097/MLR.0000000000001650.
Silva, G. C., Jiang, L., Gutman, R., Wu, W. C., Mor, V., Fine, M. J., Kressin, N. R., & Trivedi, A. N. (2021). Racial/Ethnic Differences in 30-Day Mortality for Heart Failure and Pneumonia in the Veterans Health Administration Using Claims-based, Clinical, and Social Risk-adjustment Variables. Medical care, 59(12), 1082-1089. https://doi.org/10.1097/MLR.0000000000001650
Silva, Gabriella C, et al. "Racial/Ethnic Differences in 30-Day Mortality for Heart Failure and Pneumonia in the Veterans Health Administration Using Claims-based, Clinical, and Social Risk-adjustment Variables." Medical care vol. 59,12 (2021): 1082-1089. doi: https://doi.org/10.1097/MLR.0000000000001650
Silva GC, Jiang L, Gutman R, Wu WC, Mor V, Fine MJ, Kressin NR, Trivedi AN. Racial/Ethnic Differences in 30-Day Mortality for Heart Failure and Pneumonia in the Veterans Health Administration Using Claims-based, Clinical, and Social Risk-adjustment Variables. Med Care. 2021 Dec 01;59(12):1082-1089. doi: 10.1097/MLR.0000000000001650. PMID: 34779794; PMCID: PMC8652730.
Copy Download .nbib Format: NLM
Diabetes Control During Massachusetts Insurance Reform.

Journal of racial and ethnic health disparities

Chen MT, Krzyszczyk DM, Brown AGM, Kressin N, Terrin N, Hanchate A, Suzukida J, Kher S, Price LL, LeClair AM, Byhoff E, Freund KM.
PMID: 34009559
J Racial Ethn Health Disparities. 2021 May 19; doi: 10.1007/s40615-021-01046-z. Epub 2021 May 19.

Racial/ethnic disparities in glycemic control-a key diabetes outcome measure-continue to widen, even though the overall prevalence of glycemic control in the US has improved. Health insurance coverage may be associated with improved glycemic control, but few studies examine effects...

Cite
Chen MT, Krzyszczyk DM, Brown AGM, et al. Diabetes Control During Massachusetts Insurance Reform. J Racial Ethn Health Disparities. 2021;doi: 10.1007/s40615-021-01046-z.
Chen, M. T., Krzyszczyk, D. M., Brown, A. G. M., Kressin, N., Terrin, N., Hanchate, A., Suzukida, J., Kher, S., Price, L. L., LeClair, A. M., Byhoff, E., & Freund, K. M. (2021). Diabetes Control During Massachusetts Insurance Reform. Journal of racial and ethnic health disparities, . https://doi.org/10.1007/s40615-021-01046-z
Chen, Melanie T, et al. "Diabetes Control During Massachusetts Insurance Reform." Journal of racial and ethnic health disparities vol. (2021). doi: https://doi.org/10.1007/s40615-021-01046-z
Chen MT, Krzyszczyk DM, Brown AGM, Kressin N, Terrin N, Hanchate A, Suzukida J, Kher S, Price LL, LeClair AM, Byhoff E, Freund KM. Diabetes Control During Massachusetts Insurance Reform. J Racial Ethn Health Disparities. 2021 May 19; doi: 10.1007/s40615-021-01046-z. Epub 2021 May 19. PMID: 34009559; PMCID: PMC8602445.
Copy Download .nbib Format: NLM
Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA.

Blood

Le Gouill S, Ghesquières H, Oberic L, Morschhauser F, Tilly H, Ribrag V, Lamy T, Thieblemont C, Maisonneuve H, Gressin R, Bouhabdallah K, Haioun C, Damaj G, Fornecker L, Bouhabdallah R, Feugier P, Sibon D, Cartron G, Bonnet C, André M, Chartier L, Ruminy P, Kraeber-Bodéré F, Bodet-Milin C, Berriolo-Riedinger A, Brière J, Jais JP, Molina TJ, Itti E, Casasnovas RO.
PMID: 33211799
Blood. 2021 Apr 29;137(17):2307-2320. doi: 10.1182/blood.2020008750.

Rituximab plus polychemotherapy is the standard of care in diffuse large B-cell lymphoma (DLBCL). GAINED, a randomized phase 3 trial, compared obinutuzumab to rituximab. Transplant-eligible patients (18-60 years) with an untreated age-adjusted International Prognostic Index (aaIPI) score ≥1 DLBCL...

Cite
Le Gouill S, Ghesquières H, Oberic L, et al. Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA. Blood. 2021;137(17):2307-2320doi: 10.1182/blood.2020008750.
Le Gouill, S., Ghesquières, H., Oberic, L., Morschhauser, F., Tilly, H., Ribrag, V., Lamy, T., Thieblemont, C., Maisonneuve, H., Gressin, R., Bouhabdallah, K., Haioun, C., Damaj, G., Fornecker, L., Bouhabdallah, R., Feugier, P., Sibon, D., Cartron, G., Bonnet, C., André, M., Chartier, L., Ruminy, P., Kraeber-Bodéré, F., Bodet-Milin, C., Berriolo-Riedinger, A., Brière, J., Jais, J. P., Molina, T. J., Itti, E., & Casasnovas, R. O. (2021). Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA. Blood, 137(17), 2307-2320. https://doi.org/10.1182/blood.2020008750
Le Gouill, Steven, et al. "Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA." Blood vol. 137,17 (2021): 2307-2320. doi: https://doi.org/10.1182/blood.2020008750
Le Gouill S, Ghesquières H, Oberic L, Morschhauser F, Tilly H, Ribrag V, Lamy T, Thieblemont C, Maisonneuve H, Gressin R, Bouhabdallah K, Haioun C, Damaj G, Fornecker L, Bouhabdallah R, Feugier P, Sibon D, Cartron G, Bonnet C, André M, Chartier L, Ruminy P, Kraeber-Bodéré F, Bodet-Milin C, Berriolo-Riedinger A, Brière J, Jais JP, Molina TJ, Itti E, Casasnovas RO. Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA. Blood. 2021 Apr 29;137(17):2307-2320. doi: 10.1182/blood.2020008750. PMID: 33211799.
Copy Download .nbib Format: NLM
Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers.

Thrombosis research

Haddad M, Voisin J, Reynes C, Blanc-Jouvan F, Gressin R, Mansard C, Park S, Marlu R.
PMID: 34826640
Thromb Res. 2021 Nov 22;209:1-4. doi: 10.1016/j.thromres.2021.11.013. Epub 2021 Nov 22.

No abstract available.

Cite
Haddad M, Voisin J, Reynes C, et al. Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers. Thromb Res. 2021;209:1-4doi: 10.1016/j.thromres.2021.11.013.
Haddad, M., Voisin, J., Reynes, C., Blanc-Jouvan, F., Gressin, R., Mansard, C., Park, S., & Marlu, R. (2021). Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers. Thrombosis research, 2091-4. https://doi.org/10.1016/j.thromres.2021.11.013
Haddad, Marie, et al. "Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers." Thrombosis research vol. 209 (2021): 1-4. doi: https://doi.org/10.1016/j.thromres.2021.11.013
Haddad M, Voisin J, Reynes C, Blanc-Jouvan F, Gressin R, Mansard C, Park S, Marlu R. Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers. Thromb Res. 2021 Nov 22;209:1-4. doi: 10.1016/j.thromres.2021.11.013. Epub 2021 Nov 22. PMID: 34826640.
Copy Download .nbib Format: NLM
On the origin of germ cell neoplasia in situ: Dedifferentiation of human adult Sertoli cells in cross talk with seminoma cells in vitro.

Neoplasia (New York, N.Y.)

Fink C, Baal N, Wilhelm J, Sarode P, Weigel R, Schumacher V, Nettersheim D, Schorle H, Schröck C, Bergmann M, Kliesch S, Kressin M, Savai R.
PMID: 34153645
Neoplasia. 2021 Jul;23(7):731-742. doi: 10.1016/j.neo.2021.05.008. Epub 2021 Jun 18.

Germ cell neoplasia in situ (GCNIS) is the noninvasive precursor of testicular germ cell tumors type II, the most common cancer in young men, which originates from embryonic germ cells blocked in their maturation. GCNIS is associated with impaired...

Cite
Fink C, Baal N, Wilhelm J, et al. On the origin of germ cell neoplasia in situ: Dedifferentiation of human adult Sertoli cells in cross talk with seminoma cells in vitro. Neoplasia. 2021;23(7):731-742doi: 10.1016/j.neo.2021.05.008.
Fink, C., Baal, N., Wilhelm, J., Sarode, P., Weigel, R., Schumacher, V., Nettersheim, D., Schorle, H., Schröck, C., Bergmann, M., Kliesch, S., Kressin, M., & Savai, R. (2021). On the origin of germ cell neoplasia in situ: Dedifferentiation of human adult Sertoli cells in cross talk with seminoma cells in vitro. Neoplasia (New York, N.Y.), 23(7), 731-742. https://doi.org/10.1016/j.neo.2021.05.008
Fink, Cornelia, et al. "On the origin of germ cell neoplasia in situ: Dedifferentiation of human adult Sertoli cells in cross talk with seminoma cells in vitro." Neoplasia (New York, N.Y.) vol. 23,7 (2021): 731-742. doi: https://doi.org/10.1016/j.neo.2021.05.008
Fink C, Baal N, Wilhelm J, Sarode P, Weigel R, Schumacher V, Nettersheim D, Schorle H, Schröck C, Bergmann M, Kliesch S, Kressin M, Savai R. On the origin of germ cell neoplasia in situ: Dedifferentiation of human adult Sertoli cells in cross talk with seminoma cells in vitro. Neoplasia. 2021 Jul;23(7):731-742. doi: 10.1016/j.neo.2021.05.008. Epub 2021 Jun 18. PMID: 34153645; PMCID: PMC8233172.
Copy Download .nbib Format: NLM
Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue.

Frontiers in physiology

Kresin N, Stücker S, Krämer E, Flenner F, Mearini G, Münch J, Patten M, Redwood C, Carrier L, Friedrich FW.
PMID: 30984009
Front Physiol. 2019 Mar 28;10:239. doi: 10.3389/fphys.2019.00239. eCollection 2019.

No abstract available.

Cite
Kresin N, Stücker S, Krämer E, et al. Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue. Front Physiol. 2019;10:239doi: 10.3389/fphys.2019.00239.
Kresin, N., Stücker, S., Krämer, E., Flenner, F., Mearini, G., Münch, J., Patten, M., Redwood, C., Carrier, L., & Friedrich, F. W. (2019). Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue. Frontiers in physiology, 10239. https://doi.org/10.3389/fphys.2019.00239
Kresin, Nico, et al. "Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue." Frontiers in physiology vol. 10 (2019): 239. doi: https://doi.org/10.3389/fphys.2019.00239
Kresin N, Stücker S, Krämer E, Flenner F, Mearini G, Münch J, Patten M, Redwood C, Carrier L, Friedrich FW. Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue. Front Physiol. 2019 Mar 28;10:239. doi: 10.3389/fphys.2019.00239. eCollection 2019. PMID: 30984009; PMCID: PMC6447666.
Copy Download .nbib Format: NLM
Multifunctional System for Observing, Measuring and Analyzing Stimulation-Evoked Neurochemical Signaling.

... IEEE International Symposium on Medical Measurements and Applications : proceedings. IEEE International Symposium on Medical Measurements and Applications

Kimble CJ, Boesche JB, Eaker DR, Kressin KR, Trevathan JK, Paek S, Asp AJ, McIntosh MB, Lujan JL.
PMID: 29202131
IEEE Int Symp Med Meas Appl. 2017 May;2017:349-354. doi: 10.1109/MeMeA.2017.7985901. Epub 2017 Jul 20.

The ability to measure neurotransmitter activity using implanted electrochemical sensors offers researchers a potent technique for analyzing neural activity across specific neural circuitry. We have developed a wirelessly controlled device, WINCS Harmoni, to observe and measure neurotransmitter dynamics at...

Cite
Kimble CJ, Boesche JB, Eaker DR, et al. Multifunctional System for Observing, Measuring and Analyzing Stimulation-Evoked Neurochemical Signaling. IEEE Int Symp Med Meas Appl. 2017;2017:349-354doi: 10.1109/MeMeA.2017.7985901.
Kimble, C. J., Boesche, J. B., Eaker, D. R., Kressin, K. R., Trevathan, J. K., Paek, S., Asp, A. J., McIntosh, M. B., & Lujan, J. L. (2017). Multifunctional System for Observing, Measuring and Analyzing Stimulation-Evoked Neurochemical Signaling. ... IEEE International Symposium on Medical Measurements and Applications : proceedings. IEEE International Symposium on Medical Measurements and Applications, 2017349-354. https://doi.org/10.1109/MeMeA.2017.7985901
Kimble, Christopher J, et al. "Multifunctional System for Observing, Measuring and Analyzing Stimulation-Evoked Neurochemical Signaling." ... IEEE International Symposium on Medical Measurements and Applications : proceedings. IEEE International Symposium on Medical Measurements and Applications vol. 2017 (2017): 349-354. doi: https://doi.org/10.1109/MeMeA.2017.7985901
Kimble CJ, Boesche JB, Eaker DR, Kressin KR, Trevathan JK, Paek S, Asp AJ, McIntosh MB, Lujan JL. Multifunctional System for Observing, Measuring and Analyzing Stimulation-Evoked Neurochemical Signaling. IEEE Int Symp Med Meas Appl. 2017 May;2017:349-354. doi: 10.1109/MeMeA.2017.7985901. Epub 2017 Jul 20. PMID: 29202131; PMCID: PMC5703037.
Copy Download .nbib Format: NLM
Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers.

Thrombosis research

Haddad M, Voisin J, Reynes C, Blanc-Jouvan F, Gressin R, Mansard C, Park S, Marlu R.
PMID: 34826640
Thromb Res. 2021 Nov 22;209:1-4. doi: 10.1016/j.thromres.2021.11.013. Epub 2021 Nov 22.

No abstract available.

Cite
Haddad M, Voisin J, Reynes C, et al. Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers. Thromb Res. 2021;209:1-4doi: 10.1016/j.thromres.2021.11.013.
Haddad, M., Voisin, J., Reynes, C., Blanc-Jouvan, F., Gressin, R., Mansard, C., Park, S., & Marlu, R. (2021). Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers. Thrombosis research, 2091-4. https://doi.org/10.1016/j.thromres.2021.11.013
Haddad, Marie, et al. "Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers." Thrombosis research vol. 209 (2021): 1-4. doi: https://doi.org/10.1016/j.thromres.2021.11.013
Haddad M, Voisin J, Reynes C, Blanc-Jouvan F, Gressin R, Mansard C, Park S, Marlu R. Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers. Thromb Res. 2021 Nov 22;209:1-4. doi: 10.1016/j.thromres.2021.11.013. Epub 2021 Nov 22. PMID: 34826640.
Copy Download .nbib Format: NLM
Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723].

Annals of oncology : official journal of the European Society for Medical Oncology

Fossard G, Broussais F, Coelho I, Bailly S, Nicolas-Virelizier E, Toussaint E, Lancesseur C, Le Bras F, Willems E, Tchernonog E, Chalopin T, Delarue R, Gressin R, Chauchet A, Gyan E, Cartron G, Bonnet C, Haioun C, Damaj G, Gaulard P, Fornecker L, Ghesquières H, Tournilhac O, Gomesda Silva M, Bouabdallah R, Salles G, Bachy E.
PMID: 33992519
Ann Oncol. 2021 Jul;32(7):945. doi: 10.1016/j.annonc.2021.04.021. Epub 2021 May 12.

No abstract available.

Cite
Fossard G, Broussais F, Coelho I, et al. Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723]. Ann Oncol. 2021;32(7):945doi: 10.1016/j.annonc.2021.04.021.
Fossard, G., Broussais, F., Coelho, I., Bailly, S., Nicolas-Virelizier, E., Toussaint, E., Lancesseur, C., Le Bras, F., Willems, E., Tchernonog, E., Chalopin, T., Delarue, R., Gressin, R., Chauchet, A., Gyan, E., Cartron, G., Bonnet, C., Haioun, C., Damaj, G., Gaulard, P., Fornecker, L., Ghesquières, H., Tournilhac, O., Gomesda Silva, M., Bouabdallah, R., Salles, G., & Bachy, E. (2021). Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723]. Annals of oncology : official journal of the European Society for Medical Oncology, 32(7), 945. https://doi.org/10.1016/j.annonc.2021.04.021
Fossard, G, et al. "Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723]." Annals of oncology : official journal of the European Society for Medical Oncology vol. 32,7 (2021): 945. doi: https://doi.org/10.1016/j.annonc.2021.04.021
Fossard G, Broussais F, Coelho I, Bailly S, Nicolas-Virelizier E, Toussaint E, Lancesseur C, Le Bras F, Willems E, Tchernonog E, Chalopin T, Delarue R, Gressin R, Chauchet A, Gyan E, Cartron G, Bonnet C, Haioun C, Damaj G, Gaulard P, Fornecker L, Ghesquières H, Tournilhac O, Gomesda Silva M, Bouabdallah R, Salles G, Bachy E. Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723]. Ann Oncol. 2021 Jul;32(7):945. doi: 10.1016/j.annonc.2021.04.021. Epub 2021 May 12. PMID: 33992519.
Copy Download .nbib Format: NLM
Cisatracurium Continuous Infusion Versus No Neuromuscular Blockade for Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation.

Journal of clinical pharmacology

Kressin C, Thompson Bastin M, Ather A, Gopinath A, Srour H, Schadler A, Pandya K.
PMID: 34180067
J Clin Pharmacol. 2021 Nov;61(11):1415-1420. doi: 10.1002/jcph.1933. Epub 2021 Jul 20.

The benefit of continuous infusion neuromuscular blockade concurrently with venovenous (VV) extracorporeal membrane oxygenation (ECMO) in patients with acute respiratory distress syndrome who are receiving mechanical ventilation remains unclear. Adult patients with severe acute respiratory distress syndrome requiring VV...

Cite
Kressin C, Thompson Bastin M, Ather A, et al. Cisatracurium Continuous Infusion Versus No Neuromuscular Blockade for Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation. J Clin Pharmacol. 2021;61(11):1415-1420doi: 10.1002/jcph.1933.
Kressin, C., Thompson Bastin, M., Ather, A., Gopinath, A., Srour, H., Schadler, A., & Pandya, K. (2021). Cisatracurium Continuous Infusion Versus No Neuromuscular Blockade for Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation. Journal of clinical pharmacology, 61(11), 1415-1420. https://doi.org/10.1002/jcph.1933
Kressin, Christian, et al. "Cisatracurium Continuous Infusion Versus No Neuromuscular Blockade for Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation." Journal of clinical pharmacology vol. 61,11 (2021): 1415-1420. doi: https://doi.org/10.1002/jcph.1933
Kressin C, Thompson Bastin M, Ather A, Gopinath A, Srour H, Schadler A, Pandya K. Cisatracurium Continuous Infusion Versus No Neuromuscular Blockade for Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation. J Clin Pharmacol. 2021 Nov;61(11):1415-1420. doi: 10.1002/jcph.1933. Epub 2021 Jul 20. PMID: 34180067.
Copy Download .nbib Format: NLM
Impact of Insurance Instability and Racial/Ethnic Disparities in Hospitalizations for Patients with Asthma.

Annals of the American Thoracic Society

Kher S, LeClair AM, Price LL, Terrin N, Kressin N, Hanchate A, Suzukida J, Freund KM.
PMID: 34860640
Ann Am Thorac Soc. 2021 Dec 03; doi: 10.1513/AnnalsATS.202106-698RL. Epub 2021 Dec 03.

No abstract available.

Cite
Kher S, LeClair AM, Price LL, et al. Impact of Insurance Instability and Racial/Ethnic Disparities in Hospitalizations for Patients with Asthma. Ann Am Thorac Soc. 2021;doi: 10.1513/AnnalsATS.202106-698RL.
Kher, S., LeClair, A. M., Price, L. L., Terrin, N., Kressin, N., Hanchate, A., Suzukida, J., & Freund, K. M. (2021). Impact of Insurance Instability and Racial/Ethnic Disparities in Hospitalizations for Patients with Asthma. Annals of the American Thoracic Society, . https://doi.org/10.1513/AnnalsATS.202106-698RL
Kher, Sucharita, et al. "Impact of Insurance Instability and Racial/Ethnic Disparities in Hospitalizations for Patients with Asthma." Annals of the American Thoracic Society vol. (2021). doi: https://doi.org/10.1513/AnnalsATS.202106-698RL
Kher S, LeClair AM, Price LL, Terrin N, Kressin N, Hanchate A, Suzukida J, Freund KM. Impact of Insurance Instability and Racial/Ethnic Disparities in Hospitalizations for Patients with Asthma. Ann Am Thorac Soc. 2021 Dec 03; doi: 10.1513/AnnalsATS.202106-698RL. Epub 2021 Dec 03. PMID: 34860640.
Copy Download .nbib Format: NLM
Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers.

Thrombosis research

Haddad M, Voisin J, Reynes C, Blanc-Jouvan F, Gressin R, Mansard C, Park S, Marlu R.
PMID: 34826640
Thromb Res. 2022 Jan;209:1-4. doi: 10.1016/j.thromres.2021.11.013. Epub 2021 Nov 22.

No abstract available.

Cite
Haddad M, Voisin J, Reynes C, et al. Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers. Thromb Res. 2021;209:1-4doi: 10.1016/j.thromres.2021.11.013.
Haddad, M., Voisin, J., Reynes, C., Blanc-Jouvan, F., Gressin, R., Mansard, C., Park, S., & Marlu, R. (2022). Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers. Thrombosis research, 2091-4. https://doi.org/10.1016/j.thromres.2021.11.013
Haddad, Marie, et al. "Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers." Thrombosis research vol. 209 (2022): 1-4. doi: https://doi.org/10.1016/j.thromres.2021.11.013
Haddad M, Voisin J, Reynes C, Blanc-Jouvan F, Gressin R, Mansard C, Park S, Marlu R. Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers. Thromb Res. 2022 Jan;209:1-4. doi: 10.1016/j.thromres.2021.11.013. Epub 2021 Nov 22. PMID: 34826640.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 38 entries